Cmg Global Holdings, LLC Bristol Myers Squibb CO Transaction History

Cmg Global Holdings, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $13,674 - $15,504	-285 Reduced 6.33%	4,214 $228,000
Q4 2023 Feb 16, 2024	SELL	$48.48 - $57.85 $4,848 - $5,785	-100 Reduced 2.17%	4,499 $230,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $3,185 - $3,536	-50 Reduced 1.08%	4,599 $294,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $2 - $1,690	22 Added 0.48%	4,649 $330,000
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $9,876 - $10,877	136 Added 3.03%	4,627 $356,000
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $4,549 - $5,455	74 Added 1.68%	4,491 $327,000
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $4,024 - $4,382	-65 Reduced 1.45%	4,417 $295,000
Q1 2021 Apr 15, 2021	BUY	$59.34 - $66.74 $265,961 - $299,128	4,482 New	4,482 $283,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cmg Global Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Cmg Global Holdings, LLC with notifications on news.